AN2 Therapeutics, Inc. research brief
CIK 1880438
Generated Nov. 18, 2026, 6:18 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: MENLO PARK California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- March 25, 2026 · D · 0001880438-26-000001 · Source evidence
Reported offering amount: 39999989 USD. Reported amount sold: 39999989 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “AN2 Therapeutics, Inc. research brief,” CIK 1880438, retrieved Nov. 18, 2026, 6:18 p.m.. Cite the specific accessions used. No amounts have been summed.